RECRUITING

Los Angeles Prospective GI Biliary and EUS Series

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound are increasingly being used to manage complex disease of the bile duct, pancreas and cancer. Gastroenterology patients at the Los Angeles County Hospital presents a unique and diverse patient population. Our aim is to study the biochemical, radiographic, and clinical predictors of bile duct stones. Exploratory aims include the study of the management of cholangitis, bile leaks, GI cancer diagnosis and management, and the management of pancreaticobiliary problems in the underserved. All patients managed by EUS or ERCP at the LA County \& USC University Hospitals will be enrolled in the databaseThe timing, clinical presentation, and objective details of patient presentation are recorded prospectively. Additionally the results of the subsequent ERCP and EUS procedures. Subsequent, clinical course and pathology will also be recorded.

Official Title

Prospective Evaluation of Pancreatic, Biliary, and Gastrointestinal Neoplasia by Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasound (EUS)

Quick Facts

Study Start:2010-09
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02196935

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * All patients undergoing EUS or ERCP at LAC, UH, and Norris Cancer Hospitals as standard of clinical care will be enrolled.
  1. * None of the patients will be excluded.

Contacts and Locations

Study Contact

James Buxbaum, MD
CONTACT
3234096939
jbuxbaum@usc.edu
Maria Trujillo
CONTACT
3234096939
mit@usc.edu

Principal Investigator

James L Buxbaum, MD
PRINCIPAL_INVESTIGATOR
University of Southern California School of Medicine

Study Locations (Sites)

Los Angeles County Hospital
Los Angeles, California, 91030
United States

Collaborators and Investigators

Sponsor: University of Southern California

  • James L Buxbaum, MD, PRINCIPAL_INVESTIGATOR, University of Southern California School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2010-09
Study Completion Date2025-12

Study Record Updates

Study Start Date2010-09
Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

  • Cholangitis
  • Choledocholithiasis
  • Gastrointestinal Neoplasms
  • Medically underserved area
  • Anesthesia

Additional Relevant MeSH Terms

  • Biliary Disease
  • Pancreatitis
  • Gastrointestinal Neoplasms